logo
#

Latest news with #WilliamKapp

Tony Robbins and Peter Diamandis' longevity company Fountain Life raises $18M
Tony Robbins and Peter Diamandis' longevity company Fountain Life raises $18M

Yahoo

time6 days ago

  • Business
  • Yahoo

Tony Robbins and Peter Diamandis' longevity company Fountain Life raises $18M

Eight years ago, orthopedic surgeon Dr. William Kapp attended a medical conference that changed his professional life. He had gone from a private practice doctor to co-founding a company that built critical care hospitals to then selling that company. It gave him an interest for both sides of healthcare: the medicine and business sides, he told TechCrunch. So he went to the annual conference hosted by famed physician-scientist Dr. Daniel Kraft to learn about new tech that could improve results while lowering costs. Dr. Peter Diamandis, founder and chairman of the XPRIZE Foundation, was on stage that year with Dr. Bob Hariri, a stem-cell pioneer and co-founder of several health techs like genomics company, Human Longevity, Kapp said. They discussed genomics, microbiomics, and new tech that wasn't part of mainstream medicine. Inspired, Kapp went back to his home town of Naples, Florida, and 'started a thing called Longevity Performance Center. The idea was to do early detection and then optimization of people's health,' he said. In March 2020, Diamandis (pictured above) and his buddy Tony Robbins heard of Kapp's center and visited. They had a stem cell startup called Fountain Therapeutics. Conversation soon turned toward a merger, and by October that year, the two companies became Fountain Life. Kapp remained CEO with both Diamandis and Robbins as his co-founders and board members. Today his board also includes Hariri as an adviser; Todd Wanek, CEO of Ashley Furniture Industries, as an investor; and wealthy Indian business mogul B.K. Modi as an investor as well. Fountain Life tells TechCrunch exclusively that it just raised an $18 million series B, led by EOS Ventures, with participation from most of the existing members of the board. Fountain previously raised an $80 million Series A and has raised about $108 million total, Kapp said. Longevity as a subject of serious study by the medical community is a new field. When Kapp (pictured below) first launched his center, 'We didn't know exactly what longevity meant,' he said. But over the last four or five years, much more research has been done. The first principle of longevity, he said, is 'don't die of anything stupid.' Therefore, Fountain Life's centers, of which there are four today, have a heavy focus on prevention screening, looking for illnesses and chronic conditions at their earliest stages when they tend to be asymptomatic. Blood tests and body scans gather data on over 100 biomarkers from liver fat to 'microbiome concentrations,' he said. The second principal is optimization, meaning improving those markers with scientifically validated treatments, he said. And the third principal is 'using the latest regenerative therapies under FDA trials,' to treat illness or achieve optimization. Screening tests may discover, for example, small intestinal bacterial overgrowth (SIBO), which, left untreated, may lead to certain cancers, he said. The solution, if caught early, is to restore microbiome balance with specific, prescribed microbiotics. For Fountain's members, testing is repeated every quarter or so, and patients can track results and ask questions of an AI-powered app called Zori. But it's pricey, Kapp admitted. A full subscription costs $30,000 a year, and $10,000 will cover just the testing process and AI, but not ongoing tests and medical support. Still, Kapp remembers two stories that told him this work was on the right track. The wife of a Robbins fan bought a membership for her husband, and the tests caught early-stage, asymptomatic kidney cancer. The husband is now cancer-free. When global hotelier Sam Nazarian was exploring a partnership with Fountain to put longevity centers in luxury hotels, Nazarian did Fountain's tests and found a brain aneurysm. They successfully treated it, Nazarian has publicly said. Kapp says the new funding will allow the company to open more centers. In addition to Naples; Westchester, New York; Orlando; and Dallas, a center in Houston will open in December. Centers in Los Angeles and Miami are planned for Q2 of 2026. He hopes to solve the affordability issue by working on 'clinic development' where Fountain trains medical facilities on its methodologies. Kapp says that as the tech and expertise become more widely available, this will drive down costs for access. Fountain is not the only doctor-driven longevity testing startup. Famed functional health doctor Mark Hyman has a company called Function Health. It offers a package of about 160 blood tests, with follow-up tests every three to six months, for a $500/year membership (with additional fees for additional blood tests). Its platform similarly analyzes and tracks test results, although it doesn't do full body scans or offer direct access to physicians.

Tony Robbins' and Peter Diamandis' longevity company Fountain Life raises $18M
Tony Robbins' and Peter Diamandis' longevity company Fountain Life raises $18M

TechCrunch

time6 days ago

  • Business
  • TechCrunch

Tony Robbins' and Peter Diamandis' longevity company Fountain Life raises $18M

Eight years ago, orthopedic surgeon Dr. William Kapp attended a medical conference that changed his professional life. He had gone from a private practice doctor to co-founding a company that built critical care hospitals to then selling that company. It gave him an interest for both sides of healthcare: the medicine and business sides, he told TechCrunch. So he went to the annual conference hosted by famed physician-scientist Dr. Daniel Kraft to learn about new tech that could improve results while lowering costs. Dr. Peter Diamandis, founder and chairman of the XPRIZE Foundation, was on stage that year with Dr. Bob Hariri, a stem-cell pioneer and co-founder of several health techs like genomics company, Human Longevity, Kapp said. They discussed genomics, microbiomics, and new tech that wasn't part of mainstream medicine. Inspired, Kapp went back to his home town of Naples, Florida, and 'started a thing called Longevity Performance Center. The idea was to do early detection and then optimization of people's health,' he said. In March 2020, Diamandis (pictured above) and his buddy Tony Robbins heard of Kapp's center and visited. They had a stem cell startup called Fountain Therapeutics. Conversation soon turned toward a merger, and by October that year, the two companies became Fountain Life. Kapp remained CEO with both Diamandis and Robbins as his co-founders and board members. Today his board also includes Hariri as an adviser; Todd Wanek, CEO of Ashley Furniture Industries, as an investor; and wealthy Indian business mogul B.K. Modi as an investor as well. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $600+ before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW Fountain Life tells TechCrunch exclusively that it just raised an $18 million series B, led by EOS Ventures, with participation from most of the existing members of the board. Fountain previously raised an $80 million Series A and has raised about $108 million total, Kapp said. Longevity as a subject of serious study by the medical community is a new field. When Kapp (pictured below) first launched his center, 'We didn't know exactly what longevity meant,' he said. But over the last four or five years, much more research has been done. The first principle of longevity, he said, is 'don't die of anything stupid.' Therefore, Fountain Life's centers, of which there are four today, have a heavy focus on prevention screening, looking for illnesses and chronic conditions at their earliest stages when they tend to be asymptomatic. Blood tests and body scans gather data on over 100 biomarkers from liver fat to 'microbiome concentrations,' he said. The second principal is optimization, meaning improving those markers with scientifically validated treatments, he said. And the third principal is 'using the latest regenerative therapies under FDA trials,' to treat illness or achieve optimization. Screening tests may discover, for example, small intestinal bacterial overgrowth (SIBO), which, left untreated, may lead to certain cancers, he said. The solution, if caught early, is to restore microbiome balance with specific, prescribed microbiotics. Dr. William Kapp Image Credits:Fountain Life For Fountain's members, testing is repeated every quarter or so, and patients can track results and ask questions of an AI-powered app called Zori. But it's pricey, Kapp admitted. A full subscription costs $30,000 a year, and $10,000 will cover just the testing process and AI, but not ongoing tests and medical support. Still, Kapp remembers two stories that told him this work was on the right track. The wife of a Robbins fan bought a membership for her husband, and the tests caught early-stage, asymptomatic kidney cancer. The husband is now cancer-free. When global hotelier Sam Nazarian was exploring a partnership with Fountain to put longevity centers in luxury hotels, Nazarian did Fountain's tests and found a brain aneurysm. They successfully treated it, Nazarian has publicly said. Kapp says the new funding will allow the company to open more centers. In addition to Naples; Westchester, New York; Orlando; and Dallas, a center in Houston will open in December. Centers in Los Angeles and Miami are planned for Q2 of 2026. He hopes to solve the affordability issue by working on 'clinic development' where Fountain trains medical facilities on its methodologies. Kapp says that as the tech and expertise become more widely available, this will drive down costs for access. Fountain is not the only doctor-driven longevity testing startup. Famed functional health doctor Mark Hyman has a company called Function Health. It offers a package of about 160 blood tests, with follow-up tests every three to six months, for a $500/year membership (with additional fees for additional blood tests). Its platform similarly analyzes and tracks test results, although it doesn't do full body scans or offer direct access to physicians.

Fountain Life continues mission to transform healthcare with new center openings
Fountain Life continues mission to transform healthcare with new center openings

Yahoo

time25-03-2025

  • Health
  • Yahoo

Fountain Life continues mission to transform healthcare with new center openings

The world's leading science-backed longevity membership is opening its newest wellness center location in Houston, Texas HOUSTON, March 25, 2025 /PRNewswire/ -- Fountain Life, the leading science-backed longevity company committed to proactive and data-driven global health care, today announced the scheduled October 2025 opening of its fifth precision diagnostic center, designed to help members achieve optimal health, in Houston, Texas. Fountain Life uses groundbreaking technology to offer AI-driven diagnostics, personalized health plans, and a dedicated support team, alongside advanced therapeutics that help detect potential illnesses such as cancer, cardiac issues, metabolic disorders, and neurodegenerative diseases. Their proactive approach has identified potentially life-threatening conditions in 14% of seemingly healthy members, and thanks to early detection, these conditions are now fully actionable. "Our world is undergoing a healthspan revolution, and at Fountain Life, we are at the forefront of unlocking deeper insights into the human body," said William Kapp, MD, CEO of Fountain Life. "Advances in AI, genomics, gene therapy, and cellular medicine are revealing the secrets of aging—empowering us to slow, stop, and even reverse its effects—and our next step is introducing these opportunities to the Houston community." With existing state-of-the-art centers in Florida, Texas, and New York, the new Houston center is the second location opening in Texas, driven by the popularity of the Dallas center. The center will be located in the acclaimed Park House Houston building, home to a dynamic array of social experiences, culinary offerings, fine art, cultural events and more. "At Park House, our mission is to provide members with exceptional experiences that enhance their well-being and quality of life," said Brady Wood, CEO of Woodhouse and Co-Founder, Co-Operator of Park House. "With Fountain Life opening within our building, we're bringing cutting-edge preventative health directly to our community, ensuring our members have access to the best resources to live longer, healthier lives." As interest for wellness solutions continues to grow globally, Fountain Life has future plans to expand even further. "Experts predict that this decade's medical breakthroughs could extend our health span by decades. Our mission is to ensure our members worldwide stay healthy and fully benefit from these longevity advancements," said Kapp. "We are only at the beginning of the journey." For more information on Fountain Life and its membership options, visit About Fountain LifeFountain Life is the world's leading science-backed longevity center, powered by AI. They bring together a dedicated team of longevity physicians, health coaches, and nutritionists with AI-powered diagnostics to identify and treat life-threatening diseases early, devise personalized health optimization plans, and provide 24/7 concierge medical care. Additionally, Fountain Life members have access to cutting-edge regenerative therapies designed to combat the effects of aging. We invite you to learn more at About WoodhouseWoodHouse is an experiential hospitality operator and developer specializing in luxury social clubs, fine dining, and cultural destinations. WoodHouse owns and operates Park House Dallas and Houston, chef-driven Mexican restaurant José, Dior Café by Dominique Crenn in Dallas' Highland Park Village, Citizen House Oklahoma City, Elevation Hotel & Spa in Crested Butte, Pilgrimage Music Festival, and The Moore Miami, a luxury private members club, workspace, and hotel in the Miami Design District. For more information, visit View original content to download multimedia: SOURCE Fountain Life

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store